Survey Investigation of Lead Compounds Towards Cerebral Insufficiency Improving Activity

铅化合物改善脑功能不全活性的调查研究

基本信息

  • 批准号:
    01870092
  • 负责人:
  • 金额:
    $ 9.54万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1991
  • 项目状态:
    已结题

项目摘要

1. Synthesis of beta-carbolines : Various eudistomins, marine beta-carboline alkaloids, were synthesized from N-hydroxytryptamine and cystine derivatives. First total synthesis of manzamine C, marine beta-carboline alkaloid, was completed from 1-methoxycarbonylmethyl-beta-carboline and azacycloundecene. The central ring system of manzamine A, pyrroloisoquinoline, was also synthesized. Over 40 compounds of beta-carboline derivatives prepared during these synthesis have been subjected to screening assay. Alkylation and asymmetric reduction of 3, 4-dihydro-beta-carboline have been investigated. Pictet-Spengler reaction with Lewis acid and chiral Lewis acids was investigated. Total synthesis of some marine ceramides were also completed. 2. Survey of active principles towards central nervous system in fungi : 1) Monoamine oxidase inhibitory (MAOI) activity was surveyed in fungi and lichens in vitro. MAOI activity of norsolorinic acid from Emericella and TL-1 from Talaromyces fungi was exami … More ned in vivo on anti-reserpine action. 2) Anti-endotheline-1 (or -norepinephrine) potency of several Bornean folk medicines was investigated by using smooth muscle of rat blood vessel to screen hypotensive principles. 3) HS-A, -B, and -C were isolated from Basidiomyceste, Hebeloma spoliatum, as active principle relaxing mouse small intestine like papaverine. 4) A new metabolie NFA was isolated as an inflammatory principle from an Ascomycete, Neosartorya fischeri, besides the tremorgenic principles, fumitremorgin A and B. 3. Pharmacological evaluation of cerebral insufficiency improving activity : To screen and evaluate cerebral insufficiency improving activities of beta-carbolines, several pharmacological studies were conducted ; 1) cholecystokinin (CKK) related activity, 2), calcium blocking activities, 3) potentiation of cholinergic action and 4) GABA related activities. In isolated preparations, some of beta-carbolines showed a specific antagonism to CCK, and others exerted a vasodialative action which may be related to calcium blockade. Most of compounds showing CCK antagonism in vitro also blocked the CCK-induced locomotor depression. These may be most promising as lead compound with therapeutic application. Beside the above trials, some studies were done to elucidate central mechanism of drug action. Less
1. 合成-碳碱:以n -羟色胺和胱氨酸衍生物为原料,合成了多种海洋生物碱-碳碱生物碱。首次以1-甲氧基羰基甲基-羰基-碳碱和氮杂环癸烯为原料合成了海洋生物碱-碳胺C。同时合成了曼扎胺A的中心环体系吡咯异喹啉。在这些合成过程中制备的β -羰基衍生物的40多个化合物已经进行了筛选试验。研究了3,4 -二氢-羰基羰基的烷基化反应和不对称还原反应。研究了手性路易斯酸与路易斯酸的Pictet-Spengler反应。还完成了一些海洋神经酰胺的全合成。2. 真菌对中枢神经系统的作用机理研究:1)对真菌和地衣的单胺氧化酶抑制(MAOI)活性进行了研究。研究了采自Emericella的去盐酸和Talaromyces真菌的TL-1的mao活性。2)采用大鼠血管平滑肌筛选降压原理,考察几种婆罗洲民间药物的抗内皮素-1(或-去甲肾上腺素)效价。3)从担子菌中分离得到HS-A、-B和-C,其活性成分与罂粟碱类似,是放松小鼠小肠的活性成分。4)从一种子囊菌Neosartorya fischeri中分离出一种新的代谢因子NFA,作为促炎因子,除促炎因子fuitremorgin A和b外。脑功能不全改善活性的药理学评价:为了筛选和评价β -碳碱改善脑功能不全的活性,进行了多项药理研究;1)胆囊收缩素(CKK)相关活性,2)钙阻断活性,3)胆碱能作用增强,4)GABA相关活性。在分离制剂中,一些β -碳胺对CCK具有特异性拮抗作用,而另一些则具有血管舒张作用,这可能与钙阻断有关。大多数在体外显示CCK拮抗作用的化合物也能阻断CCK诱导的运动抑制。这些可能是最有希望作为先导化合物的治疗应用。除上述试验外,还进行了一些研究,以阐明药物作用的主要机制。少

项目成果

期刊论文数量(250)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Yogo: "Vasoconstrictor effect of endothelin in isolated perfused stomach of the rat in comparison with noradrenaline and serotonin." Japan.J.Pharmacol.52. 160-163 (1990)
K.Yogo:“与去甲肾上腺素和血清素相比,内皮素在大鼠离体灌注胃中的血管收缩作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S. Yano: "Stimulatory effect of some therapeutic drugs used for improving cerebral insufficiency on gastric acid secretion in rats." Pharmacology. 40. 205-210 (1990)
S. Yano:“一些用于改善脑供血不足的治疗药物对大鼠胃酸分泌的刺激作用。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
中川 昌子: "Synthetic studies on Manzamine A I: DielsーAlder Reaction of5,6ーdihydroー2ーpyridone." Heterocycles. 31. 999-1002 (1990)
Masako Nakakawa:“Manzamine A I 的合成研究:5,6-二氢-2-吡啶酮的 Diel-Alder 反应。” 31. 999-1002 (1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
奥山 恵美: "Monoamine oxidase inhibitors from a lichen,<Soloria>___ー <crocea>___ー (L.) Ach." 生薬学雑誌 発表予定. 45. (1991)
Emi Okuyama:“来自地衣的单胺氧化酶抑制剂,<Soloria>____ <crocea>____ (L.) Ach.,即将出版。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
矢野 真吾: "Increasing effect of sodium 3ーethy1ー7ーisopropy1ー1ーazuーlenesulfonate 1/3 hydrate (KT1ー32),novel antiulcer agent,on gastric mucosal blood flow in anesthetized rats" Res. Comm. Chem. Pathol. Pharmacol.70. 253-256 (1990)
Shingo Yano:“新型抗溃疡剂 3-乙基 7-异丙基 1-1-azu-lenesulfonate 1/3 水合物 (KT1-32) 对麻醉大鼠胃粘膜血流的增加作用”Res Comm。病理学。70。253-256(1990)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HINO Tohru其他文献

HINO Tohru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HINO Tohru', 18)}}的其他基金

SYNTHETIC STUDIES ON BIOLOGICALLY ACTIVE TRYPTOPHAN METABOLITES.
生物活性色氨酸代谢物的综合研究。
  • 批准号:
    62470134
  • 财政年份:
    1987
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Harnessing Atropisomerism in beta-Carbolines for the Discovery of New Reactions and Small Molecule Probes
利用 β-咔啉中的阻转异构现象来发现新反应和小分子探针
  • 批准号:
    10730343
  • 财政年份:
    2023
  • 资助金额:
    $ 9.54万
  • 项目类别:
Modulation of a Candida albicans Virulence Trait by Lactobacillus-Secreted Beta-Carbolines
乳杆菌分泌的β-咔啉对白色念珠菌毒力特性的调节
  • 批准号:
    439408
  • 财政年份:
    2020
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Studentship Programs
RUI: Asymmetric Synthesis of Atropisomeric beta-Carbolines
RUI:阻转异构β-咔啉的不对称合成
  • 批准号:
    1955132
  • 财政年份:
    2020
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Standard Grant
Involvement of beta-carbolines in the symptoms of alcohol withdrawal
β-咔啉与酒精戒断症状的关系
  • 批准号:
    02807066
  • 财政年份:
    1990
  • 资助金额:
    $ 9.54万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
BETA-CARBOLINES: VALIUM AGONISTS AND ANTAGONISTS
β-咔啉:安定激动剂和拮抗剂
  • 批准号:
    3375898
  • 财政年份:
    1988
  • 资助金额:
    $ 9.54万
  • 项目类别:
BETA-CARBOLINES: VALIUM AGONISTS AND ANTAGONISTS
β-咔啉:安定激动剂和拮抗剂
  • 批准号:
    3375892
  • 财政年份:
    1988
  • 资助金额:
    $ 9.54万
  • 项目类别:
BETA-CARBOLINES: VALIUM AGONISTS AND ANTAGONISTS
β-咔啉:安定激动剂和拮抗剂
  • 批准号:
    3375900
  • 财政年份:
    1988
  • 资助金额:
    $ 9.54万
  • 项目类别:
BETA-CARBOLINES: VALIUM AGONISTS AND ANTAGONISTS
β-咔啉:安定激动剂和拮抗剂
  • 批准号:
    3375897
  • 财政年份:
    1988
  • 资助金额:
    $ 9.54万
  • 项目类别:
BETA-CARBOLINES: VALIUM AGONISTS AND ANTAGONISTS
β-咔啉:安定激动剂和拮抗剂
  • 批准号:
    3375899
  • 财政年份:
    1988
  • 资助金额:
    $ 9.54万
  • 项目类别:
MPTP, BETA-CARBOLINES AND THE ETIOLOGY OF PARKINSONISM
MPTP、β-咔啉和帕金森病的病因学
  • 批准号:
    3407918
  • 财政年份:
    1986
  • 资助金额:
    $ 9.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了